Pharmacokinetic studies in pregnant women

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The only way to determine appropriate medication dosing during pregnancy is to evaluate the pharmacokinetics and pharmacodynamics of individual medications in pregnant women. This type of clinical investigation can present a variety of challenges and concerns. This chapter summarizes what is known about physiologic changes in pregnancy and the impact these changes can have on drug disposition, and provides a model approach for completing pharmacokinetic studies in women during pregnancy.

Original languageEnglish
Title of host publicationPharmacokinetics in Drug Development
PublisherSpringer US
Pages195-209
Number of pages15
Volume3
ISBN (Print)9781441979360
DOIs
StatePublished - 2011

Fingerprint

Pregnant Women
Pharmacokinetics
Pregnancy
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Renbarger, J., & Haas, D. (2011). Pharmacokinetic studies in pregnant women. In Pharmacokinetics in Drug Development (Vol. 3, pp. 195-209). Springer US. https://doi.org/10.1007/978-1-4419-7937-7_9

Pharmacokinetic studies in pregnant women. / Renbarger, Jamie; Haas, David.

Pharmacokinetics in Drug Development. Vol. 3 Springer US, 2011. p. 195-209.

Research output: Chapter in Book/Report/Conference proceedingChapter

Renbarger, J & Haas, D 2011, Pharmacokinetic studies in pregnant women. in Pharmacokinetics in Drug Development. vol. 3, Springer US, pp. 195-209. https://doi.org/10.1007/978-1-4419-7937-7_9
Renbarger J, Haas D. Pharmacokinetic studies in pregnant women. In Pharmacokinetics in Drug Development. Vol. 3. Springer US. 2011. p. 195-209 https://doi.org/10.1007/978-1-4419-7937-7_9
Renbarger, Jamie ; Haas, David. / Pharmacokinetic studies in pregnant women. Pharmacokinetics in Drug Development. Vol. 3 Springer US, 2011. pp. 195-209
@inbook{c2796093a06b4d168773766a1a45d437,
title = "Pharmacokinetic studies in pregnant women",
abstract = "The only way to determine appropriate medication dosing during pregnancy is to evaluate the pharmacokinetics and pharmacodynamics of individual medications in pregnant women. This type of clinical investigation can present a variety of challenges and concerns. This chapter summarizes what is known about physiologic changes in pregnancy and the impact these changes can have on drug disposition, and provides a model approach for completing pharmacokinetic studies in women during pregnancy.",
author = "Jamie Renbarger and David Haas",
year = "2011",
doi = "10.1007/978-1-4419-7937-7_9",
language = "English",
isbn = "9781441979360",
volume = "3",
pages = "195--209",
booktitle = "Pharmacokinetics in Drug Development",
publisher = "Springer US",

}

TY - CHAP

T1 - Pharmacokinetic studies in pregnant women

AU - Renbarger, Jamie

AU - Haas, David

PY - 2011

Y1 - 2011

N2 - The only way to determine appropriate medication dosing during pregnancy is to evaluate the pharmacokinetics and pharmacodynamics of individual medications in pregnant women. This type of clinical investigation can present a variety of challenges and concerns. This chapter summarizes what is known about physiologic changes in pregnancy and the impact these changes can have on drug disposition, and provides a model approach for completing pharmacokinetic studies in women during pregnancy.

AB - The only way to determine appropriate medication dosing during pregnancy is to evaluate the pharmacokinetics and pharmacodynamics of individual medications in pregnant women. This type of clinical investigation can present a variety of challenges and concerns. This chapter summarizes what is known about physiologic changes in pregnancy and the impact these changes can have on drug disposition, and provides a model approach for completing pharmacokinetic studies in women during pregnancy.

UR - http://www.scopus.com/inward/record.url?scp=84900204852&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84900204852&partnerID=8YFLogxK

U2 - 10.1007/978-1-4419-7937-7_9

DO - 10.1007/978-1-4419-7937-7_9

M3 - Chapter

SN - 9781441979360

VL - 3

SP - 195

EP - 209

BT - Pharmacokinetics in Drug Development

PB - Springer US

ER -